MALDI-imaging reveals TYB4 to classify diploid from aneuploid colon cancer

  • Gemoll T
  • Strohkamp S
  • Schillo K
  • et al.
ISSN: 2296-5270
Citations of this article
Mendeley users who have this article in their library.


Background: DNA aneuploidy has been identified as a prognostic factor for epithelial malignancies. In this study, we compared diploid and aneuploid colon cancer tissues against normal mucosa of the colon by means of matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS). Material and Methods: DNA image cytometry determined the ploidy status of tissue samples that were subsequently subjected to MALDI-IMS. After obtaining protein profiles through direct analysis of tissue sections, a discovery and a validation set were used to predict ploidy and disease status by applying proteomic classification algorithms [Supervised Neural Network (SNN) and Receiver Operating Characteristic (ROC)]. Clinical target validation was performed by immunohistochemistry using tissue microarrays (TMA) comprising healthy controls as well as diploid and aneuploid colorectal carcinomas. Results: SNN algorithm categorized 99% of normal mucosa and 90% of colon carcinoma as well as 99% of diploid and 94% of aneuploid colon cancers correctly. Validation of both comparisons showed a correct classification of normal mucosa in 92%, tumors in 96%, and diploid and aneuploid colon cancers in 92% and 78%, respectively. Five peaks (m/z 2,396 and 4,977 for the diploid vs. aneuploid comparison and m/z 3,375, 6,663, 8,581 for the normal mucosa vs. carcinoma comparison) reached significance in both SNN and ROC analysis. Among these, m/z 4,977 was identified as thymosin beta 4 (TYB4). TYB4 showed expression differences also in clinical samples using a tissue microarray of normal mucosa, diploid and aneuploid colorectal carcinomas and could serve to predict overall survival. Conclusion: Our data underscore the potential of MALDI-IMS proteomic algorithms to reveal significant molecular details from distinct tumor subtypes such as different ploidy types.




Gemoll, T., Strohkamp, S., Schillo, K., Thorns, C., & Habermann, J. (2016). MALDI-imaging reveals TYB4 to classify diploid from aneuploid colon cancer. Oncol. Res. Treat., 39, 72. Retrieved from U2 - L72212518

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free